HCPCS Modifier LU

Modifier LU describes a fractionated payment of Chimeric Antigen Receptor T-cell Therapy with an implementation date of January 31, 2023.

MLN Matters: MM12928

For additional information, please refer to cms.gov for additional information and any updates.

(Information correct as of the date this article was written. Please refer to CMS.gov for any updates to this policy.)